Company Filing History:
Years Active: 2004-2013
Title: Harumi Ariyasu: Innovator in Biotechnology
Introduction
Harumi Ariyasu is a prominent inventor based in Okayama, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and genetic engineering.
Latest Patents
Ariyasu holds 2 patents, with her latest inventions focusing on monoclonal antibodies specific for human interferon-alpha subtype alpha 8. This invention aims to provide a monoclonal antibody specific to interferon α subtype α8 (IFNα8) and its mutant proteins. The patent outlines methods for detecting and purifying IFNα8 and its mutant proteins, as well as a therapeutic agent for treating diseases related to IFNα8. Additionally, she has developed a DNA sequence that encodes murine trehalase, which has applications in transgenic and knockout animals.
Career Highlights
Ariyasu is associated with Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, where she continues to advance her research and innovations in biotechnology. Her work has been instrumental in enhancing the understanding and application of monoclonal antibodies in medical treatments.
Collaborations
Some of her notable coworkers include Tsunetaka Ohta and Shigeharu Fukuda, who have collaborated with her on various projects within the company.
Conclusion
Harumi Ariyasu's contributions to biotechnology through her patents and research have positioned her as a key figure in the field. Her innovative work continues to pave the way for advancements in medical treatments and genetic engineering.